tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Longeveron granted FDA Type C Meeting ahead of ELPIS II data readout
PremiumThe FlyLongeveron granted FDA Type C Meeting ahead of ELPIS II data readout
1M ago
Longeveron granted U.S. patent for method of treating female sexual dysfunction
Premium
The Fly
Longeveron granted U.S. patent for method of treating female sexual dysfunction
2M ago
Longeveron granted Canadian patent covering laromestrocel administration
Premium
The Fly
Longeveron granted Canadian patent covering laromestrocel administration
3M ago
Longeveron Inc. Earnings Call: Mixed Sentiments Amid Clinical Progress
PremiumCompany AnnouncementsLongeveron Inc. Earnings Call: Mixed Sentiments Amid Clinical Progress
4M ago
Longeveron Inc. Reports Q3 2025 Financial Results
Premium
Company Announcements
Longeveron Inc. Reports Q3 2025 Financial Results
4M ago
Longeveron reports Q3 EPS (39c), consensus (26c)
Premium
The Fly
Longeveron reports Q3 EPS (39c), consensus (26c)
4M ago
Longeveron CEO Wa’el Hashad to step down
PremiumThe FlyLongeveron CEO Wa’el Hashad to step down
6M ago
Longeveron Inc. Earnings Call: Progress Amid Challenges
Premium
Company Announcements
Longeveron Inc. Earnings Call: Progress Amid Challenges
6M ago
Longeveron: Buy Rating Backed by Promising Clinical Developments and Strategic Financial Outlook
Premium
Ratings
Longeveron: Buy Rating Backed by Promising Clinical Developments and Strategic Financial Outlook
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100